论文信息 - The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD - 字舞流文

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

J. Smith | Dave Singh | M. Belvisi | I. Psallidas | A. Jauhiainen | C. Astbury | J. Beier | E. Jiménez | C. A. Da Silva | A. Lei | S. Necander | U. Wählby Hamrén | W. Xin